Loading…
Attending this event?
Monday, June 17 • 11:00am - 12:00pm
#111: China Town Hall

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-525-L04-P; CME 1.00; RN 1.00

In this forum, speakers from the National Medical Products Administration (NMPA) and the Center for Drug Evaluation (CDE) will present and discuss the latest information on regulation, regulatory science, and drug review and approval. Speakers will also discuss recent development in clinical research in China. Attendees will have an opportunity to discuss the issues related to drug regulation with NMPA officials.

Learning Objectives

Summarize the latest information on the National Medical Products Administration’s activities in drug regulation; Describe the recent update on the progress in drug review, approval and clinical research in China; Identify challenges in drug development and regulation in China.

Chair

Ling Su, PhD

Speaker

Opening Remarks and Introductions
Lili Cao, MS

Initiatives to Bring More New Drugs to Patients, and Faster
Zhimin Yang, MD

Recent Developments in Regulatory Science and Regulation
Jiangyong Yu

Advancing Clinical Research in China: A Clinical Oncologist’s Perspective
Shun Lu


Speakers
avatar for Ling Su

Ling Su

Research Fellow, Shenyang Pharmaceutical University, Yeehong Business School, China
Dr. Ling Su is a Research Fellow in Shengyang Pharmaceutical University Yeehong Business School and a Venture Partner in Lilly Asia Ventures (LAV). He has 30 years of experience in drug regulatory and development. He had worked in various R&D management positions in the pharma industry... Read More →
avatar for Lili Cao

Lili Cao

Deputy Director, China Center for Food and Drug International Exchange, National Medical Products, China
Lili Cao is the Deputy Director-General, China Center for Food & Drug Int’l Exchange (CCFDIE), National Medical Products Administration (NMPA). She received her bachelor degree at Nankai University, and master degree at London School of Economics and Political Science, majoring... Read More →
avatar for Shun Lu

Shun Lu

Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest Hospital,, Shanghai Jiaotong University, China
Shun Lu, MD, PhD, is a Director of the Oncology Department and Professor at Shanghai Chest Hospital. Dr. Lu serves on the International Affairs Committee of the American Society of Clinical Oncology, and Multidisciplinary Cancer Management Courses Working Group. He is also a member... Read More →
avatar for Zhimin Yang

Zhimin Yang

Deputy Director, Center for Drug Evaluation, National Medical Products Administration (NMPA), China
Dr. Yang is theDeputy Director-General ,Center for Drug Evaluation of the National Medical Products Administration. Graduated from Peking University Medical Center, majoring in clinical medicine. She used to be a known pediatrician working at Peking University People's Hospital. In... Read More →
avatar for Jiangyong Yu

Jiangyong Yu

Director, Department of Drug Registration, National Medical Products Administration (NMPA), China
Dr. Yu Jiangyong, Doctor of Science, Chief Pharmacist. Currently, he is the consultant and director of division of TCMs and Ethno-Medicines, Department of Drug Registration (Department of TCMs and Ethno-Medicines Regulation) of China's NMPA.

Monday June 17, 2024 11:00am - 12:00pm PDT
Room 6D San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  09: Regulatory, Forum